Learn more at LeadIQ.com

Insights

Precision Pregnancy Tests Sera Prognostics specializes in precision biomarker-based tests for pregnancy complications like premature birth, preeclampsia, and gestational diabetes, offering a unique opportunity to provide valuable solutions to healthcare providers and expecting mothers.

Competitive Benchmarking By positioning itself among leading biotechnology research companies such as Genomic Health, Natera, and Invitae, Sera Prognostics can leverage industry insights to identify market gaps and offer competitive alternatives to customers seeking advanced pregnancy care solutions.

Financial Stability and Growth Potential With a substantial funding of $100M and a revenue range between $10M - 50M, Sera Prognostics exhibits financial stability and growth potential, making it an attractive partner for investments and collaborations in the biotechnology sector.

Innovative Tech Stack Utilizing a tech stack featuring advanced tools like SAS, PHP, and jQuery UI, Sera Prognostics demonstrates a commitment to innovation in biotechnology research, offering a technological edge that can appeal to tech-savvy healthcare institutions and professionals.

Employee-Centric Culture Sera Prognostics' values and culture, as showcased on its website, highlight a commitment to employee engagement and well-being, presenting an opportunity for businesses focusing on corporate social responsibility to collaborate and support the company's mission.

Similar companies to Sera Prognostics

Sera Prognostics Tech Stack

Sera Prognostics uses 8 technology products and services including SAS, Twitter Emoji (Twemoji), FancyBox, and more. Explore Sera Prognostics's tech stack below.

SAS
Business Intelligence
Twitter Emoji (Twemoji)
Font Scripts
FancyBox
Javascript Libraries
jQuery UI
Javascript Libraries
Open Graph
Miscellaneous
PHP
Programming Languages
Autoptimize
Web Platform Extensions
Nginx
Web Servers

Media & News

Sera Prognostics's Email Address Formats

Sera Prognostics uses at least 1 format(s):

Sera Prognostics Email Formats	Example	Percentage
FLast@seraprognostics.com	JDoe@seraprognostics.com	78%
FirstL@seraprognostics.com	JohnD@seraprognostics.com	17%
First@seraprognostics.com	John@seraprognostics.com	4%
First.Last@seraprognostics.com	John.Doe@seraprognostics.com	1%

Frequently Asked Questions

Where is Sera Prognostics's headquarters located?

Sera Prognostics's main headquarters is located at 2749 East Parleys Way Salt Lake City, UT 84109 US. The company has employees across 4 continents, including North AmericaSouth AmericaAsia.

What is Sera Prognostics's phone number?

You can contact Sera Prognostics's main corporate office by phone at

+1-801-990-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sera Prognostics's stock symbol?

Sera Prognostics is a publicly traded company; the company's stock symbol is SERA.

What is Sera Prognostics's official website and social media links?

Sera Prognostics's official website is seraprognostics.com and has social profiles on LinkedIn.

How much revenue does Sera Prognostics generate?

As of September 2024, Sera Prognostics's annual revenue reached $35M.

What is Sera Prognostics's SIC code NAICS code?

Sera Prognostics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sera Prognostics have currently?

As of September 2024, Sera Prognostics has approximately 74 employees across 4 continents, including North AmericaSouth AmericaAsia. Key team members include Chief Information Officer (cio): R. G. H.Chief Data Officer: P. K.Vice President Of Commercialization: D. R.. Explore Sera Prognostics's employee directory with LeadIQ.

What industry does Sera Prognostics belong to?

Sera Prognostics operates in the Biotechnology Research industry.

What technology does Sera Prognostics use?

Sera Prognostics's tech stack includes SASTwitter Emoji (Twemoji)FancyBoxjQuery UIOpen GraphPHPAutoptimizeNginx.

What is Sera Prognostics's email format?

Sera Prognostics's email format typically follows the pattern of . Find more Sera Prognostics email formats with LeadIQ.

How much funding has Sera Prognostics raised to date?

As of September 2024, Sera Prognostics has raised $100M in funding. The last funding round occurred on Apr 28, 2021 for $100M.

When was Sera Prognostics founded?

Sera Prognostics was founded in 2008.

Sera Prognostics

Sera Prognostics

Biotechnology ResearchUtah, United States51-200 Employees

Sera Prognostics is a leading proteomic and bioinformatics company dedicated to improving the lives of women and babies through precision biomarker-based tests designed to enhance pregnancy care. Our vision is to deliver pivotal information to physicians early in pregnancy to help them to improve the health of their patients and reduce costs of healthcare delivery. 
The PreTRM® Test reports to a physician the individualized risk of premature birth, enabling earlier proactive interventions in patients with higher risk. We're also developing a robust pipeline of innovative tests focused on other complications of pregnancy, including preeclampsia, gestational diabetes, growth restriction, and others.
Learn more about our values, culture, and open positions on our website.

Company Overview

Headquarters: 2749 East Parleys Way Salt Lake City, UT 84109 US
Phone number: ✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-801-990-****
Website: seraprognostics.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: SERA
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2008
Employees: 51-200

Media & News

Funding & Financials

$100M
Sera Prognostics has raised a total of $100M of funding over 11 rounds. Their latest funding round was raised on Apr 28, 2021 in the amount of $100M.
$10M$50M
Sera Prognostics's revenue is in the range of $10M$50M

Funding & Financials

$100M
Sera Prognostics has raised a total of $100M of funding over 11 rounds. Their latest funding round was raised on Apr 28, 2021 in the amount of $100M.
$10M$50M
Sera Prognostics's revenue is in the range of $10M$50M

Company Leadership

R. G. H.
Chief Information Officer (cio)
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. K.
Chief Data Officer
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. R.
Vice President Of Commercialization
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. M.
Vice President – Quality | Regulatory
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. L.
Vice President Consumer Marketing
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

J. C.
Head Of Marketing
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. F.
Vice President, Clinical Operations
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. P.
Sr. Vice President, Laboratory Operations And Technology Development
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. M.
Vice President – Quality | Regulatory
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. C. H.
Vice President, Quality & Regulatory
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sera Prognostics and Millions of Other Companies
Sign up for full access to Sera Prognostics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.